Effects of remote care of patients with poorly controlled type 1 diabetes included in an experimental telemonitoring programme
Authors:
- 1 November 2021
- journal article
- research article
- Published by Elsevier in Diabetes & Metabolism
- Vol. 47 (6) , 101251
Abstract
No abstract availableKeywords
Funding Information
- Abbott Diabetes Care
This publication has 13 references indexed in Scilit:
- ENDOCRINOLOGY IN THE TIME OF COVID-19: Remodelling diabetes services and emerging innovationEuropean Journal of Endocrinology, 2020
- Continuous Glucose Monitoring in Adults with Type 1 Diabetes: Real-World Data from the German/Austrian Prospective Diabetes Follow-Up RegistryDiabetes Technology & Therapeutics, 2020
- Disease-Management-Programs in the Field of Diabetes Mellitus with Identification of the Best Practice in Europe: A Scoping ReviewHormone and Metabolic Research, 2020
- Randomized Study to Evaluate the Impact of Telemedicine Care in Patients With Type 1 Diabetes With Multiple Doses of Insulin and Suboptimal HbA1c in Andalusia (Spain): PLATEDIAN StudyDiabetes Care, 2019
- Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in RangeDiabetes Care, 2019
- State of Type 1 Diabetes Management and Outcomes from the T1D Exchange in 2016–2018Diabetes Technology & Therapeutics, 2019
- Assessing the economic value of maintained improvements in Type 1 diabetes management, in terms of HbA1c, weight and hypoglycaemic event incidenceDiabetic Medicine, 2018
- The burden and treatment of diabetes in FranceGlobalization and Health, 2014
- The Diabeo Software Enabling Individualized Insulin Dose Adjustments Combined With Telemedicine Support Improves HbA1c in Poorly Controlled Type 1 Diabetic PatientsDiabetes Care, 2011
- Epidemiology of Type 1 DiabetesEndocrinology and Metabolism Clinics of North America, 2010